Introduction survival or augment programmed cell death (Table 1) . Apoptotic cell death is a critical feature of the regulated A striking feature of the Bcl-2 family members is their development of multicellular organisms. An individual ability to dimerize. The pro-apoptotic member Bad can cell must integrate signals delivered by death-inducing dimerize with Bcl-2 and Bcl-x L , and overexpression of and survival-promoting receptors to determine its fate Bad counters the survival-promoting effect of Bcl-2 and in the context of the organism as a whole. A major focus Bcl-xL. Bax also forms heterodimers with Bcl-2 and Bclon the regulation of apoptosis has been on the identificax L , although apparently with lower affinity than does tion of new molecules that influence cell survival in either
Bad. The ratio of Bcl-2 to Bax appears to determine a positive or a negative fashion. One of the best studied the fate of transfected cells, an excess of Bcl-2 resulting survival genes is bcl-2, the first member identified of a in survival but an excess of Bax resulting in death. Howgrowing family of genes that participate in the control ever, a simple agonist-antagonist relationship between of apoptosis. The bcl-2 gene family contains both antithe pro-apoptotic and anti-apoptotic family members apoptotic and pro-apoptotic members (for review, see is complicated by the observation that pairs of antiYang and Korsmeyer, 1996) . To date, most studies inapoptotic members, such as Bcl-2 and Bcl-x L, can also vestigating the function of these genes have relied on form heterodimers. Furthermore, depending on the simple overexpression. However, the levels of expresassay system used, some family members can promote sion of Bcl-2-related proteins do not always predict the either cell death or cell survival (Kiefer et al., 1995;  Corability of a cell to resist death-promoting stimuli. Such tazzo and Schor, 1996; Middleton et al., 1996) . Neverthedata have been interpreted as evidence for Bcl-2-indeless, a model for the regulation of cell survival by Bcl-2 pendent mechanisms of regulating apoptosis (Strasser family proteins has been suggested in which Bax homoet al., 1995) . dimers comprise an active trigger for cell death. In the Several recent experiments have indicated that postpresence of an excess of Bcl-2 or Bcl-x L , heterodimeritranslational modification of Bcl-2-related proteins may zation with Bax prevents the formation of toxic Bax play an important role in regulating their ability to prohomodimers, resulting in survival. The additional presmote cell survival. First, the ability of the chemotheraence of Bad would then disrupt Bcl-2-Bax and Bclpeutic agent taxol to induce phosphorylation of Bcl-2 x L -Bax heterodimers, liberating Bax once again to selfhas been implicated as a mechanism by which it can dimerize and promote death. However, in an equally promote death in the face of high expression of Bcl-2 plausible model, Bcl-2 and Bcl-x L might be active repres- (Haldar et al., 1995) . Consistent with this observation, sors of cell death, and dominant heterodimerization with deletion of a putative negative regulatory loop that conBax or Bad may block the ability of the former molecules tains the major serine/threonine phosphorylation sites to prevent apoptosis. In favor of this model is the obserin Bcl-2 enables Bcl-2 to promote cell survival under vation that specific mutations in Bcl-x L that abrogate conditions where it is normally inactive (Chang et al., binding to Bax do not eliminate the ability of Bcl-x L to 1996). Second, Bcl-2 appears to be cleaved by proteprevent death (Cheng et al., 1996) . ases activated during apoptosis, which may explain the One common feature of most Bcl-2-related proteins death of lymphocytes infected with HIV (Strack et al., is a carboxy-terminal hydrophobic domain. In Bcl-2 and 1996). Two papers in the current issue of Cell demonBcl-x L , at least, this domain is responsible for their localstrate a third mechanism for post-translational modificaization to the endoplasmic reticulum, the outer mitotion, serine-phosphorylation of the pro-apoptotic Bcl-2 chondrial membrane, and the outer nuclear membrane. family member, Bad. These observations have opened An exception is the death-promoting relative Bad, which an avenue of investigation into the signal transduction lacks a carboxy-terminal hydrophobic stretch, sugcascades triggered by extracellular survival signals that gesting that it is not an integral membrane protein. can modify the function of Bcl-2 family proteins.
Growth Factors Induce Survival Signals Bcl-2 Protects against Death
Several growth factors originally characterized for their Overexpression of Bcl-2 in cytokine-dependent cell lines ability to induce proliferation have been shown to be enhances cell survival following growth factor withpotent regulators of cell survival (Harrington et al., 1994) . drawal, a property that first implicated Bcl-2 as a regulaFor example, the cytokines IL-2, IL-4, and IL-7 promote tor of apoptosis rather than as a growth-promoting oncogene (Yang and Korsmeyer, 1996). Bcl-2 protects a the survival of resting T cells that do not proliferate in By selectively focusing on specific signaling path- sponse to GM-CSF but does not sustain cell survival (Kinoshita et al., 1995) . These observations suggest that
Ras, Raf-1, or both can play an important role in transBad ϩ ducing survival signals in some experimental systems.
Phosphorylation of Bcl-2
The Bcl-2 family consists of proteins that share a common domain of approximately 66 amino acids, comprising the Bcl-2 homology
The relationship between Bcl-2 function and the known regions 1 and 2 (BH1 and BH2). Paradoxically, a given family member pathways of receptor-mediated signal transduction is may perform either function, depending on the cell system utilized not clear. Bcl-2 is phosphorylated on serine residues in (Kiefer et al., 1995; Cortazzo and Schor, 1996; Middleton et al., 1996) .
response to a variety of stimuli (May et al., 1994; Haldar Functional outcome may correlate with the ability to dimerize with et al., 1995; Chen and Faller, 1996) . Although the funcspecific other family members, or with how extracellular signals tion of this phosphorylation is controversial, several obregulate phosphorylation. The family members listed are those for which functional data have been published.
servations suggest that Bcl-2 can be inactivated by phosphorylation ( Figure 1 ). Follicular lymphoma cells with a t(14;18) translocation do not contain phosphoryresponse to these signals. GM-CSF and IL-3 promote lated Bcl-2. Treatment of lymphoid cells with the chemothe survival of myeloid cells, while erythropoietin facilitherapeutic drug taxol or the phosphatase inhibitor okatates survival of the erythroid lineage. Similarly, IGF-1 daic acid induces phosphorylation of Bcl-2 and results augments the survival of fibroblasts, and NGF and CNTF in cell death. In addition, Bcl-2 is phosphorylated in the can foster the survival of neuronal cell lines. For the pre-B cell line WEHI-231, a system in which Bcl-2 does most part, exposure to these factors does not appear not protect well against apoptosis. Interestingly, phosto modulate the expression of Bcl-2.
phorylation of Bcl-2 appears to depend upon the presAt least two signal transduction mechanisms have ence of a flexible loop domain. Deletion of the loop been found to be activated in response to growth facdomain results in marked augmentation in the protective tors, one dependent on tyrosine kinases and the other effect of Bcl-2 (Chang et al., 1996) . Thus, the loop doinitiated by the guanine nucleotide binding protein, Ras.
main may have a negative-regulatory function that is Ras is a GTPase-containing protein that is active when dependent upon serine phosphorylation, which in turn in a GTP-bound state and inactive when the bound GTP may attenuate the protective effect of Bcl-2. is hydrolyzed to GDP. It is localized to the inner aspect Bcl-2 has been reported to coimmunoprecipitate with of the plasma membrane via a farnesylation sequence Raf-1 (Wang et al., 1994) , although it is likely that this at its carboxy terminus. One role of activated Ras is to interaction is indirect. However, Raf-1 does not appear recruit other enzymes to the plasma membrane, preto phosphorylate Bcl-2 directly, and Bcl-2 also can assosumably to bring them into proximity with key activators ciate with a kinase-dead variant of Raf-1. Thus, the kiand substrates. The serine/threonine kinase Raf-1 is the nase responsible for phosphorylation of Bcl-2 remains best characterized downstream Ras effector (Morrison, to be elucidated. Interaction of Bcl-2 with p21 Ras (Chen 1995). Targeting Raf-1 itself to the membrane by introand Faller, 1996) and with p23 R-Ras also has been reduction of a farnesylation sequence can bypass a need for activated Ras.
ported. Most data are consistent with a negative regulatory role for Bcl-2 phosphorylation, which lowers the apoptotic threshold and promotes cell death despite the presence of Bcl-2. However, the phosphorylation sites on Bcl-2 have not been mapped in all systems, and it remains possible that distinct phosphorylation sites may regulate Bcl-2 function differently. In addition to the outer mitochondrial membrane, Bcl-2 also distributes to the endoplasmic reticulum and outer nuclear membrane.
Phosphorylation of Bad
A role for the phosphorylation of Bcl-2-related proteins has now been extended to Bad, a pro-apoptotic member of the Bcl-2 family. Zha and colleagues (1996, this issue) have demonstrated that Bad is phosphorylated on serine residues in response to IL-3, and becomes dephosphorylated upon growth factor withdrawal. Interestingly, nonphosphorylated Bad associates with Bcl-x L in coimmunoprecipitation experiments. Phosphorylation of Bad renders it unable to bind to Bcl-x L . Instead, the phosphorylated form of Bad associates with 14-3-3, a protein that interacts with several signaling enzymes including Raf-1, apparently through a binding pocket for serinephosphorylated sequences (Muslin et al., 1996) . Indeed, Bad contains a phosphorylation-dependent consensus sequence for 14-3-3 recognition. The Bad-14-3-3 complex appears to reside in the cytosol, thus preventing the interaction of Bad with Bcl-x L at the mitochondrial membrane. Transfection with a mutant Bad in which the regulatory serine phosphorylation sites were substituted results in a failure to bind 14-3-3 and accelerates apoptosis upon IL-3 withdrawal. These observations suggest that one mechanism by which growth factors promote survival is through the ability to induce the phosphorylation of Bad, resulting in its association with 14-3-3 ( Figure 2A ). This sequesters Bad away from BclxL, thus freeing Bcl-xL to exert its anti-apoptotic effect. In contrast, growth factor withdrawal may promote apoptosis as a result of dephosphorylation of Bad, either phosphorylates Bad, which prevents it from interacting with Bcl-xL.
Which Kinases Are Involved?
This frees Bcl-xL to execute its anti-apoptotic function (Zha et al.,
Although Raf-1 can phosphorylate Bad in vitro, the sites 1996). The ability of phosphorylated versus nonphosphorylated Bad of phosphorylation are distinct from those modified by to interact with Bcl-2 has not been reported. In (B), Raf-1 is translo-IL-3 exposure in vivo (Zha et al., 1996) . Nevertheless, cated to Bcl-2 at the mitochondria, initiating a local signaling casusing a fusion protein between the catalytic domain of cade resulting in the serine phosphorylation of Bad. Presumably, these events can be induced by exposure to a growth factor such Raf-1 and green fluorescent protein, Wang and colas IL-3 (Wang et al., 1996) .
leagues have found that overexpression of Bcl-2 can induce the localization of Raf-1 to mitochondria (Wang et al., 1996, this issue) . By analogy to the approach of would occur independently from Ras, since the Raf-1 farnesylation to target Raf-1 to the plasma membrane, construct employed lacks the Ras binding domain. FurWang et al. targeted Raf-1 to mitochondria by fusing it thermore, other studies by this group indicate that Bclto the transmembrane domain of the yeast outer mito-2-Raf-1 interactions do not modulate Raf-1 kinase activchondrial membrane protein, Mas70p. Transfection of ity (Wang et al., 1994 ).
IL-3-dependent cells with this construct renders them
If Raf-1 is not directly responsible for serine phosphorresistant to death upon growth factor withdrawal, even ylation of Bcl-2 or Bad, then which kinases are? With in the absence of Bcl-2 overexpression. This effect derespect to Bcl-2, the fact that signaling events leading pends on an active Raf-1 kinase, as mitochondrial tarto the activation of stress-induced kinases Jnk and p38 geting of a kinase-dead mutant augments death, percan promote cell death (Xia et al., 1995) suggests that haps by interfering with endogenous Raf-1 function.
participants in these pathways may phosphorylate Thus, one role of Bcl-2 may be to target Raf-1 to the Bcl-2. For Bad, although its phosphorylation is induced outer mitochondrial membrane, bringing it into proximity by PMA and inhibited by staurosporine, PKC does not with a specific set of substrates. In the studies of Wang appear to phosphorylate Bad at the correct site in vitro et al. mitochondrial localization of Raf-1 is necessary (Zha et al., 1996) . Heart muscle kinase does phosphoryfor it to induce Bad phosphorylation. However, the data late Bad at the correct site, suggesting that a PKAof Zha and colleagues suggest that Raf-1 probably does related kinase might operate in vivo. However, it is plaunot directly phosphorylate Bad. If both groups are corsible to consider that the kinase that phosphorylates rect, then Raf-1 translocation to the mitochondria may Bad is downstream from Raf-1 but does not participate initiate a local signaling cascade that leads secondarily in the cascade leading to Erk activation. Although the to Bad phosphorylation ( Figure 2B) . only known physiologic substrate for Raf-1 is MEK, eviOne limitation of the studies of Wang and colleagues dence in multiple systems suggests that additional Raf-1 is the lack of a mechanism for how IL-3-mediated signal substrates exist, one of which could be a kinase capable transduction might promote Raf-1 recruitment to the mitochondrial membrane by Bcl-2. This presumably of phosphorylating Bad.
Conclusions that regulate those enzymes, and the role of these signaling events in the control of cell survival in response The mechanism by which Bcl-2 and Bcl-xL promote cell to diverse extracellular ligands. survival is not yet understood. However, the establishment of functional links to signal transduction events Selected Reading has provided several new perspectives on this question. One viewpoint, supported by their intracellular localizaChang, B.S., Minn, A.J., Muchmore, S.W., Fesik, S.W., and Thomption, is that Bcl-2-related proteins may serve as signaling son, C.B. (1996) . EMBO. J., in press. receptors for intracellular organelles (Figure 1 ). Serine Chen, C.Y., and Faller, D.V. (1996) . J. Biol. Chem. 271, 2376 Chem. 271, -2379 kinases activated by pro-apoptotic stimuli would lead Cheng, E.H.Y., Levine, B., Boise, L.H., Thompson, C.B., and Hard- to the phosphorylation of Bcl-2, thus inactivating its wick, J.M. (1996) . Nature 379, 554-556. ability to serve as a survival receptor. These kinases Cortazzo, M., and Schor, N.F. (1996) . Cancer Res. 56, 1199 Res. 56, -1203 would be counterbalanced by the activity of specific Haldar, S., Jena, N., and Croce, C.M. (1995) . Proc. Natl. Acad. Sci.
phosphatases. USA 92, [4507] [4508] [4509] [4510] [4511] A second perspective is that phosphorylation of Bad
Harrington, E.A., Bennett, M.R., Fanidi, A., and Evan, G.I. (1994). may provide a key survival-promoting decision point. EMBO. J. 13, [3286] [3287] [3288] [3289] [3290] [3291] [3292] [3293] [3294] [3295] A kinase activated by growth factors might maintain Kiefer, M.C., Brauer, M.J., Powers, V.C., Wu, J.J., Umansky, S.R., Tomel, L.D., Barr, P.J. (1995) . Nature 374, [736] [737] [738] [739] phosphorylation of Bad, resulting in persistent association of Bad with 14-3-3 in the cytosol (Figure 2A ). Bad and translocates to the cytosol.
Wang, H.G., Miyashita, T., Takayama, S., Sato, T., Torigoe, T., Kra-A third potential mechanism by which Bcl-2 proteins jewski, S., Tanaka, S., Hovey, L., Troppmair, J., Rapp, U., and Reed, may function is suggested by the three-dimensional J.C. (1994) . Oncogene 9, 2751 Oncogene 9, -2756 structure of Bcl-xL, analysis of which has revealed two Wang, H.G., Rapp, U.R., and Reed, J.C. (1996) . Cell, this issue. central hydrophobic ␣-helices surrounded by five amXia, Z., Dickens, M., Raingeaud, J., Davis, R.J., and Greenberg, M.E. phipathic helices, as well as a 60 residue flexible loop (1995) . Science 270, 1326 Science 270, -1331 ( Muchmore et al., 1996) . This tertiary structure has ho- Yang, E., and Korsmeyer, S.J. (1996) . Blood 88, [386] [387] [388] [389] [390] [391] [392] [393] [394] [395] [396] [397] [398] [399] [400] [401] mology with the membrane translocation domain of colZha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S.J. (1996). icins and of diphtheria toxin. The latter is thought to Cell, this issue. dimerize and form a membrane pore that is regulated by pH. By analogy, Bcl-xL and Bcl-2 may form a pore involved in the homeostasis of cellular organelles, particularly of the mitochondria, that may protect cells against electrochemical changes that occur under stressful physiologic conditions. Bad might interfere with the assembly or the function of such pores, thus eliminating the ability of Bcl-2 and Bcl-xL to protect cells against death.
In summary, although protection of cells against apoptotic death can be influenced by the level of expression of Bcl-2 and Bcl-x L , post-translational modification of Bcl-2 family members appears to be important as well. In the situations reported to date, phosphorylation appears to be inhibitory. Phosphorylation of Bcl-2 on serine residues appears to inhibit its anti-apoptotic function. Serine phosphorylation of Bad results in its binding to 14-3-3 rather than to Bcl-x L , thus blocking the proapoptotic function of Bad. Further investigation will be required to identify the kinases and phosphatases that directly modulate Bcl-2 and Bad, the signaling pathways
